Logo for Mauna Kea Technologies SA

Mauna Kea Technologies Investor Relations Material

Latest events

Logo for Mauna Kea Technologies SA

Q2 2023 TU

Mauna Kea Technologies
Logo for Mauna Kea Technologies

H1 2024 & Q3 2024 TU

15 Oct, 2024
Logo for Mauna Kea Technologies

H2 2023 & 2024 Q1 TU

25 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Mauna Kea Technologies SA

Access all reports
Mauna Kea Technologies SA is a French medical device company that specializes in developing and marketing advanced optical biopsy systems. The company's flagship product, Cellvizio, is a probe-based Confocal Laser Endomicroscopy (pCLE) platform. This technology allows physicians to obtain real-time, high-resolution cellular images during endoscopic procedures, primarily for detecting abnormalities in the gastrointestinal and pulmonary tracts, particularly in cancer patients. The Cellvizio system is designed to improve diagnostic accuracy and support more immediate treatment decisions, with applications across multiple medical specialties. Mauna Kea Technologies is headquartered in Paris, France, and its shares are listed on the Euronext Paris.